Testosterone Acetate Thiosemicarbazone and Its Metal Complexes Against Breast Cancer
Author Information
Author(s): Anupa Murugkar, Bindu Unnikrishnan, Subhash Padhye, Ramesh Bhonde, Simon Teata, Evangelia Triantafillou, Ekkehard Sinn
Primary Institution: Department of Chemistry, University of Pune
Hypothesis
Can testosterone acetate thiosemicarbazone and its metal complexes effectively target and inhibit human breast cancer cells?
Conclusion
The platinum complex showed the highest antitumor activity against the MCF-7 breast cancer cell line compared to the copper complex and the ligand itself.
Supporting Evidence
- The study synthesized testosterone acetate thiosemicarbazone and characterized it using X-ray crystallography.
- Metal complexes of the synthesized ligand were tested for their in vitro activity against the MCF-7 breast cancer cell line.
- The platinum complex exhibited the highest cytotoxicity compared to the copper complex and the ligand.
Takeaway
Researchers made a new drug from testosterone and tested it to see if it could help fight breast cancer. They found that one version of the drug worked really well.
Methodology
The study involved synthesizing testosterone acetate thiosemicarbazone and its metal complexes, followed by testing their activity against the MCF-7 human breast cancer cell line.
Limitations
The study did not specify the exact sample size or the range of concentrations tested for the compounds.
Want to read the original?
Access the complete publication on the publisher's website